BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 15262102)

  • 1. The cervical cancer epidemic that screening has prevented in the UK.
    Peto J; Gilham C; Fletcher O; Matthews FE
    Lancet; 2004 Jul 17-23; 364(9430):249-56. PubMed ID: 15262102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.
    Simonella L; Canfell K
    Cancer Causes Control; 2013 Sep; 24(9):1727-36. PubMed ID: 23832659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical screening in England and Wales: its effect has been underestimated.
    Herbert A
    Cytopathology; 2000 Dec; 11(6):471-9. PubMed ID: 11194078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cervical cancer mortality in the Americas.
    Robles SC; White F; Peruga A
    Bull Pan Am Health Organ; 1996 Dec; 30(4):290-301. PubMed ID: 9041740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening in Serbia.
    Kesić V; Jovićević-Bekić A; Vujnović M
    Coll Antropol; 2007 Apr; 31 Suppl 2():31-6. PubMed ID: 17598502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer in New Zealand: national and regional trends.
    Cox B; Borman B
    N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
    Martin-Hirsch P; Rash B; Martin A; Standaert B
    BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented.
    Raffle AE; Alden B; Quinn M; Babb PJ; Brett MT
    BMJ; 2003 Apr; 326(7395):901. PubMed ID: 12714468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
    Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cervical cancer after 10 years of nationally coordinated screening].
    Haldorsen T; Skare GB; Steen R; Thoresen SO
    Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in mortality from uterine cancer in relation to mass screening.
    Christopherson WM; Scott MA
    Acta Cytol; 1977; 21(1):5-9. PubMed ID: 264759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer.
    Beral V; Hermon C; Muñoz N; Devesa SS
    Cancer Surv; 1994; 19-20():265-85. PubMed ID: 7534630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England.
    Sasieni P; Adams J
    Lancet; 2001 May; 357(9267):1490-3. PubMed ID: 11377601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.
    Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G
    Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in cervical cancer mortality in Korea 1993-2002: corrected mortality using national death certification data and national cancer incidence data.
    Shin HR; Park S; Hwang SY; Kim JE; Jung KW; Won YJ; Hwang SS; Yim SH; Choi KS; Park EC; Park SY; Kim JW; Lee HP
    Int J Cancer; 2008 Jan; 122(2):393-7. PubMed ID: 17722111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer in Croatia: state of the art and possibilities for prevention.
    Znaor A; Strnad M
    Coll Antropol; 2007 Apr; 31 Suppl 2():37-40. PubMed ID: 17598503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projections of cervical cancer mortality and incidence in New Zealand: the possible impact of screening.
    Cox B; Skegg DC
    J Epidemiol Community Health; 1992 Aug; 46(4):373-7. PubMed ID: 1431710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.
    Vaccarella S; Lortet-Tieulent J; Plummer M; Franceschi S; Bray F
    Eur J Cancer; 2013 Oct; 49(15):3262-73. PubMed ID: 23751569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
    Bray F; Loos AH; McCarron P; Weiderpass E; Arbyn M; Møller H; Hakama M; Parkin DM
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.